SUBMIT YOUR ABSTRACT

Abstract Submission

The 2027 ANZUP ASM Convening Committee is pleased to invite abstract submissions from all professional disciplines and groups involved in researching and treating genitourinary cancers for consideration in the 2027 ASM program.

All accepted abstracts will be presented in poster format and displayed throughout the ASM. In addition, a limited number of abstracts may be selected for an oral presentation, with the opportunity to be considered for a Best of the Best Award.

The selection of abstracts for oral presentation will be made by the ASM Convening Committee. During the abstract submission process, you will have the opportunity to indicate if you wish to be considered for an oral presentation in addition to a poster presentation.

Important Dates


Abstract submissions close: 9am AEST Monday 22 March 2027

Successful applicants notified: from Monday 19 April 2027

Submission Guidelines

  • Abstracts must be submitted via the online submission portal - see button above.
  • There is no limit to the number of abstracts that may be submitted by each author.
  • All abstracts must be presented in English and be a piece of original work.
  • Encore abstracts are permitted but must be disclosed at the time of submission.
  • You will be asked to identify one presenting author during the abstract submission process.
  • Abstracts submitted for presentation will be published exactly as submitted. Accepted abstracts will be published in the Asia-Pacific Journal of Clinical Oncology (Wiley Online) following the ASM. Therefore all submissions should be checked for accuracy and spelling prior to submission.
  • Please ensure that all authors are included in your abstract in the order you would like the names to appear.
  • Please do not make multiple submissions of the same abstract, or a similar topic. Consider combining them into one submission.
  • To enable you to edit and access your abstract before the submission deadline, please note your username and password to log back in and amend.
  • You will be sent an acknowledgement email once your abstract submission is complete and submitted. If you do not receive this acknowledgement email, please contact the meeting manager on the details below.
  • Please ensure that you select “Save as a Draft ” should you wish to come back to complete and submit your submission at a later time. However, please ensure that you DO return to submit your final submission, otherwise the submission will show as incomplete and will not be considered.
  • Once submitted, the abstract can no longer be edited. You can email the meeting manager to make further changes on the details below.
  • The final decision on acceptances and on publication and presentation formats are at the discretion of the ASM Convening Committee.
  • Successful authors must register and pay to attend the full ASM, in-person.

Abstract content

  • Please write your title in full with no abbreviations. Maximum 30 words.
  • Text should be entered in upper and lower (sentence) case. Please do not type abstract titles or text all in capital letters.
  • There is a maximum of 300 words for the abstract. References may be added up to a maximum overall total of 350 words.
  • Images and tables should NOT be included.
  • The abstract should include:
  • Introduction and objectives;
  • Methods;
  • Results;
  • Conclusions. NOTE: Conclusions of the form – “results will be discussed” – are not acceptable.
  • Only standard abbreviations may be used as per the BJUI guidelines (please click here to view). For abbreviations not listed on the BJUI list, please write in full in the first instance with the abbreviation in brackets.
  • Add author names and affiliations in full with the presenting author identified at the time of submission.

Questions


Please do not hesitate to contact anzupasm@catalystevents.com.au or phone +61 2 9419 4889 at any stage if you have any questions.